Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Ownership Summary
Rigel Pharmaceuticals is owned by 6.50% institutional investors, 2.59% insiders, and 90.92% retail investors. Soleus capital management is the largest institutional shareholder, holding 6.35% of RIGL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Rigel Pharmaceuticals shares.
RIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rigel Pharmaceuticals | 6.50% | 2.59% | 90.92% |
| Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
| Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Soleus capital management | 1.13M | 6.35% | $20.34M |
| Creative planning | 15.59K | 0.09% | $280.48K |
| Barclays | 10.57K | 0.01% | $88.00K |
| Farther finance advisors | 667.00 | 0.00% | $11.22K |
| Versant capital management | 123.00 | 0.00% | $2.07K |
| Eversource wealth advisors | 63.00 | 0.00% | $1.06K |
| Legal & general group | - | - | - |
| Prudential financial | - | - | - |
| Voya investment management | - | - | - |
| Hexagon capital partners | 2.00 | - | $34.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Soleus capital management | 1.13M | 1.46% | $20.34M |
| Versant capital management | 123.00 | 0.00% | $2.07K |
| Farther finance advisors | 667.00 | 0.00% | $11.22K |
| Creative planning | 15.59K | 0.00% | $280.48K |
| Eversource wealth advisors | 63.00 | 0.00% | $1.06K |
| Legal & general group | - | - | - |
| Prudential financial | - | - | - |
| Voya investment management | - | - | - |
| Hexagon capital partners | 2.00 | - | $34.00 |
| National bank of canada /fi/ | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Creative planning | 15.59K | 0.00% | 15.54K |
| Versant capital management | 123.00 | 0.00% | 123.00 |
| Hexagon capital partners | 2.00 | - | - |
| Eversource wealth advisors | 63.00 | 0.00% | - |
| Huntington national bank | 1.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -15.36M |
| Blackrock | - | - | -14.80M |
| Morgan stanley | - | - | -14.44M |
| Vanguard group | - | - | -9.37M |
| Acadian asset management | - | - | -5.47M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Versant capital management | 123.00 | 0.00% | 123.00 | $2.07K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Synergy asset management | -15.00 |
| Loring wolcott & coolidge fiduciary advisors llp/ma | -27.00 |
| Harbour investments | -40.00 |
| Nelson, van denburg & campbell wealth management group | -356.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 3 | -97.60% | 1,156,951 | -90.41% | 6 | 0.14% | 1 | -98.78% | 1 | -95.24% |
| Dec 31, 2024 | 6 | 50.00% | 1,212 | 65.35% | - | 39369.05% | 2 | 100.00% | - | - |
| Sep 30, 2024 | 4 | -55.56% | 733 | -94.24% | - | 7854.79% | 1 | -50.00% | - | -100.00% |
| Jun 30, 2024 | 9 | -92.62% | 12,725 | -99.99% | - | 0.00% | 2 | -96.00% | 5 | -87.18% |
| Mar 31, 2024 | 122 | 3.39% | 111,001,285 | 4.17% | 63 | 1.69% | 50 | -9.09% | 39 | 30.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 548.78K | 3.07% | - |
| Vanguard Total Stock Mkt Idx Inv | 548.78K | 3.07% | - |
| iShares Russell 2000 ETF | 448.88K | 2.51% | 219.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 272.78K | 1.53% | 469.00 |
| SPDR® S&P Biotech ETF | 241.40K | 1.35% | 312.00 |
| Fidelity Small Cap Index | 173.56K | 0.97% | -254.00 |
| Delaware Healthcare I | 160.00K | 0.91% | - |
| Macquarie Healthcare I | 160.00K | 0.90% | - |
| Zacks Small Cap Equity Strategy | 133.63K | 0.75% | 5.25K |
| Lazard US Sm Cap Eq WW Dist EUR | 119.62K | 0.67% | 39.23K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 04, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $42.60K |
| Feb 05, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $38.02K |
| Feb 05, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $39.38K |
| Feb 04, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $44.46K |
| Feb 04, 2025 | RODRIGUEZ RAUL R | CEO, President | Sell | $103.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 6 |
RIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools